Daily Round Up 4/14/16: Qualcomm, Atyr Pharma, Bloomin' Brands, Ambient Water

by: InsiderInsights

Tables of the top insider purchases and sales filed with the SEC on 4/14/16, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history.

Educational note from InsiderInsights:

Insider filing volumes are at a seasonal low point due to companies closing trading windows to their insiders until quarterly earnings are released. As a result, the dollar values of trades featured in our Daily round Up articles (particularly the purchases) will likely be lower than usual until early May.

On Today's Tables:

Insider trades were rated Significant at:

  • Atyr Pharma (NASDAQ:LIFE).

Insider trades were rated Nearly Significant at:

Insider trades were considered Insignificant at:

  • Tangoe (OTC:TNGO);
  • S & W Seed (NASDAQ:SANW);
  • Royal HI Orchards (OTCQX:NNUTU);
  • Ollie S Bargain Outlet (NASDAQ:OLLI);
  • Tortoise Mlp Fund (NYSE:NTG);
  • Blackrock Municipal 2030 Target Term Trust (NYSE:BTT);
  • Zimmer Biomet (NYSE:ZBH);
  • Rsp Permian (NYSE:RSPP);
  • JPMorgan Chase (NYSE:JPM);
  • Godaddy (NYSE:GDDY), and;
  • Cintas (NASDAQ:CTAS).

There is a Conflicted Insider Signal (both purchases & sales) at:

  • Iconix Brand (NASDAQ:ICON).

There is an IPO or Known Corporate Action at:

  • Aeglea Biotherapeutics (NASDAQ:AGLE).

It's difficult to argue significance for most transactions made during IPOs, or when insiders make trades during a known corporate action.

Insider Purchases

#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 Clearlake Capital Iv Finance BO Tangoe TNGO B $8,719,328
2 Lilly Eli BO Aeglea Biotherapeutics AGLE JB* $5,000,000
3 Barclays BO Iconix Brand ICON B $310,574
4 Ebrahimi Farhad F BO Royal HI Orchards NNUTU B $87,228
5 Hendrickson Thomas DIR Ollie S Bargain Outlet OLLI B $46,586
6 Schimmel Paul DIR Atyr Pharma LIFE B $37,865
7 Wynnefld SmCap Val BO S & W Seed SANW B $14,297
8 Heath Charles E DIR Tortoise Mlp Fund NTG B $8,115
9 Soccio Phillip O Br Mun 2030 Target Term Tr BTT B $7,513
10 Wende Mike SEC,DIR Ambient Water AWGI B $4,820

Source: | Key to Insider Title and Trans Type Codes :
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales

#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 Kkr Fund BO Godaddy GDDY JS* $288,035,040
2 Silver Lake Group BO Godaddy GDDY JS* $144,017,520
3 Zames Matthew E COO JPMorgan Chase JPM AS $2,788,441
4 Wallace Family BO Rsp Permian RSPP AS $2,333,875
5 Smith Gordon VP JPMorgan Chase JPM AS $1,990,421
6 Thompson James H VP Qualcomm QCOM AS $1,805,300
7 Holloman James Phillip PR,COO Cintas CTAS S $1,753,334
8 Grob Matthew S VP Qualcomm QCOM AS $1,686,993
9 Sullivan Chris Thomas DIR Bloomin Brands BLMN AS $1,393,755
10 Florin Daniel P VP,CFO Zimmer Biomet ZBH AS $1,320,000 | Key to Insider Title and Trans Type Codes :
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more microcap stocks. Please be aware of the risks associated with these stocks.